🔎 Trials Near Me

Hem › Interstitiella lungsjukdomar › Arizona

Kliniska studier för Interstitiella lungsjukdomar i Arizona

13 studier för Interstitiella lungsjukdomar söker deltagare vid platser i Arizona.

Städer i Arizona

Officiell studietext (engelska)

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Arizona Heart Rhythm Center, Phoenix
  • University of Arizona, Tucson
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 29 sep. 2026 · NCT05798923

Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

  • Phoenix, Phoenix
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 8 sep. 2026 · NCT07473700

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Scottsdale
  • GSK Investigational Site, Tucson
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT05878717

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • Banner University Medical Center, Phoenix
  • Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic Institute, Phoenix
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 2 sep. 2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Dignity Health - St. Joseph's Hospital and Medical Center, Phoenix
  • Arizona Pulmonary Specialists, Ltd., Scottsdale
RekryterarFas 3
Ålder 18 till 80 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • Banner Health - University Medical Center Phoenix, Phoenix
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 26 aug. 2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Arizona, Tucson
RekryterarObservationsstudie
Ålder 21 och äldre · Alla kön · Uppdaterad 12 aug. 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Arizona Pulmonary Specialists, Phoenix
RekryterarFas 2
Ålder 18 till 80 · Alla kön · Uppdaterad 10 aug. 2026 · NCT07175038

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Banner University Medical Center Phoenix Lung Institute, Phoenix
  • Norton Thoracic Institute, Phoenix
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Arizona Pulmonary Specialists, Phoenix
RekryterarObservationsstudie
Ålder 18 till 80 · Alla kön · Uppdaterad 26 juni 2026 · NCT06129240

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

  • Mayo Clinic in Arizona, Scottsdale
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 20 mars 2026 · NCT06751069

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • HonorHealth Research Institute, Scottsdale
RekryterarFas 2
Ålder 40 och äldre · Alla kön · Uppdaterad 12 nov. 2025 · NCT05975983

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.